Literature DB >> 29026001

Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis.

Santiago Martinez Sosa1, Kenneth J Smith2.   

Abstract

The deep and periventricular white matter is preferentially affected in several neurological disorders, including cerebral small vessel disease (SVD) and multiple sclerosis (MS), suggesting that common pathogenic mechanisms may be involved in this injury. Here we consider the potential pathogenic role of tissue hypoxia in lesion development, arising partly from the vascular anatomy of the affected white matter. Specifically, these regions are supplied by a sparse vasculature fed by long, narrow end arteries/arterioles that are vulnerable to oxygen desaturation if perfusion is reduced (as in SVD, MS and diabetes) or if the surrounding tissue is hypoxic (as in MS, at least). The oxygen crisis is exacerbated by a local preponderance of veins, as these can become highly desaturated 'sinks' for oxygen that deplete it from surrounding tissues. Additional haemodynamic deficiencies, including sluggish flow and impaired vasomotor reactivity and vessel compliance, further exacerbate oxygen insufficiency. The cells most vulnerable to hypoxic damage, including oligodendrocytes, die first, resulting in demyelination. Indeed, in preclinical models, demyelination is prevented if adequate oxygenation is maintained by raising inspired oxygen concentrations. In agreement with this interpretation, there is a predilection of lesions for the anterior and occipital horns of the lateral ventricles, namely regions located at arterial watersheds, or border zones, known to be especially susceptible to hypoperfusion and hypoxia. Finally, mitochondrial dysfunction due to genetic causes, as occurs in leucodystrophies or due to free radical damage, as occurs in MS, will compound any energy insufficiency resulting from hypoxia. Viewing lesion formation from the standpoint of tissue oxygenation not only reveals that lesion distribution is partly predictable, but may also inform new therapeutic strategies.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  demyelination; hypoxia; oligodendrocytes; therapy; vasculature; watershed

Mesh:

Year:  2017        PMID: 29026001     DOI: 10.1042/CS20170981

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  29 in total

1.  The glymphatic system and its role in cerebral homeostasis.

Authors:  Helene Benveniste; Rena Elkin; Paul M Heerdt; Sunil Koundal; Yuechuan Xue; Hedok Lee; Joanna Wardlaw; Allen Tannenbaum
Journal:  J Appl Physiol (1985)       Date:  2020-10-01

2.  In vivo imaging and analysis of cerebrovascular hemodynamic responses and tissue oxygenation in the mouse brain.

Authors:  Kassandra Kisler; Divna Lazic; Melanie D Sweeney; Shane Plunkett; Mirna El Khatib; Sergei A Vinogradov; David A Boas; Sava Sakadži; Berislav V Zlokovic
Journal:  Nat Protoc       Date:  2018-05-24       Impact factor: 13.491

3.  Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.

Authors:  Sneha Pandya; Ulrike W Kaunzner; Sandra M Hurtado Rúa; Nancy Nealon; Jai Perumal; Timothy Vartanian; Thanh D Nguyen; Susan A Gauthier
Journal:  J Neuroimaging       Date:  2020-06-24       Impact factor: 2.486

Review 4.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

5.  Characterizing the time course of cerebrovascular reactivity in multiple sclerosis.

Authors:  John A Lincoln; Khader M Hasan; Refaat E Gabr; Jerry S Wolinsky
Journal:  J Neuroimaging       Date:  2022-02-14       Impact factor: 2.324

Review 6.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

Review 7.  Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors.

Authors:  Lucia Monti; Lucia Morbidelli; Alessandro Rossi
Journal:  Biomark Insights       Date:  2018-05-18

8.  Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Eric E Smith; Jeff F Dunn; V Wee Yong
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

9.  Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing.

Authors:  Susan J van Rensburg; Armand V Peeters; Ronald van Toorn; Johan Schoeman; Kelebogile E Moremi; Carel J van Heerden; Maritha J Kotze
Journal:  Mol Genet Metab Rep       Date:  2019-03-23

10.  Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Authors:  João J Cerqueira; D Alastair S Compston; Ruth Geraldes; Mario M Rosa; Klaus Schmierer; Alan Thompson; Michela Tinelli; Jacqueline Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.